MedidataVoice: An Inside Look At Eli Lilly And Company’s Emerging Markets Strategy
Tomorrow we will publish an in-depth interview with Eli Lilly and Company’s President of Emerging Markets Chito Zulueta on the company’s strategies as it enters new markets and how it can approve clinical development in these sometimes-volatile markets. For years life sciences companies have talked about the prospects for new business […]

Vía Forbes Real Time